Sy Mukherjee

Sy Mukherjee is a former health care reporter for Fortune.

Page 18 of 100

  • COVID forgotten communitiesNewsletters

    The communities we forget during COVID-19

    By
  • Gilead remdesivir coronavirus FDAHealth

    Gilead’s remdesivir won’t be a COVID-19 miracle cure, but it’s still an important first step

    By
  • Arriving at camp on Faith’s eighth birthday, Aug. 4, 2019.Health

    The coronavirus pandemic is impacting critical research into neuromuscular diseases

    By
  • Coronavirus treatment approachNewsletters

    The 3-pronged approach to defeating the coronavirus

    By
  • Dr. Hina Chawla with patient Laurie Halligan on Friday, April 17, 2020, in San Carlos, Calif.Health

    Elective surgeries—mostly paused due to the pandemic—are critical to hospital finances

    By
  • TESTING, TESTING: Drive-through swabs for coronavirus have become the preferred method, as shown here in Malaga, Spain.Magazine

    Big Pharma has the chance to come to the world’s rescue

    By
  • Mom squeezing hand sanitizer onto littler daughter’s handsNewsletters

    Coronavirus tests and their discontents

    By
  • Coronavirus Drive Thru Testing Penn State Health Saint JosephHealth

    There are 32 authorized coronavirus tests so far—here’s how they differ

    By
  • coronavirus,3d renderNewsletters

    The key problem to solve in the quest for coronavirus treatments

    By
  • Former Vice President Joe Biden speaks in Wilmington, Del., on March 12, 2020, about the coronavirus outbreak.Health

    Joe Biden’s health care plan for the coronavirus and beyond

    By
  • Coronavirus earthNewsletters

    Coronavirus is (literally) shaking up how the world moves

    By
  • J&J coronavirusNewsletters

    J&J’s coronavirus vaccine could hit the market by 2021

    By
  • The Johnson & Johnson logo is arranged for a photograph in New York, U.S., on Monday, April 15, 2013. Johnson & Johnson is scheduled to release earnings data on April 16. Photographer: Scott Eells/Bloomberg via Getty ImagesHealth

    Johnson & Johnson hopes to have its promising coronavirus vaccine approved by early 2021

    By
  • Coronavirus cases U.S.Newsletters

    The U.S. now has the most coronavirus cases in the world

    By
  • Henry Schein, which produces everything from pharmaceuticals to dental equipment, has a new pinprick blood test that could be done onsite, and wouldn’t require any lab work.Newsletters

    Henry Schein says its coronavirus test takes just 15 minutes, and there’s no swab necessary

    By